People: Impax Laboratories Inc (IPXL.OQ)

IPXL.OQ on NASDAQ Stock Exchange Global Select Market

2:29am IST
Change (% chg)

$-0.20 (-0.98%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Nornhold, Jeffrey 

Mr. Jeffrey D. Nornhold is Senior Vice President, Technical Operations of Impax Laboratories Inc. He has served as our Senior Vice President of Technical Operations since April 2014 and is responsible for the Company's manufacturing, supply chain, quality and technical operations. Previously, Jeff served as our Senior Vice President, Global Quality Affairs from March 2011 to April 2014 and was responsible for establishing the foundation for a sustainable quality and compliance program. Jeff joined us from Watson Pharmaceuticals, Inc. (now Actavis plc) where he was the Vice President, Quality Operations – International from March 2010 to March 2011 and was responsible for outside of the U.S. manufacturing sites for both dosage and active pharmaceutical ingredients. While at Watson, he also served as Vice President, U.S. Quality Operations leading the development and execution of quality initiatives for all U.S. sites from February 2007 to March 2010. Prior to joining Watson in 2000, he held numerous leadership positions within the pharmaceuticals industry. He earned a Bachelor of Science degree in chemistry from Bowling Green State University and a Master's in Business Administration from the University of Southern California Marshall School of Business.

Basic Compensation

Total Annual Compensation, USD 1,578,520
Restricted Stock Award, USD 488,400
Long-Term Incentive Plans, USD --
All Other, USD 511,470
Fiscal Year Total, USD 2,578,390

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Burr


Paul Bisaro


Bryan Reasons


Douglas Boothe


Michael Nestor


Robert Stewart

As Of  31 Dec 2016